Integris Medtech, a diversified medical technology platform, has filed preliminary papers with markets regulator Sebi to raise funds through an initial public offering (IPO), with people familiar with the matter pegging the issue size between Rs 3,500 crore and Rs 4,000 crore.
With this, the company, which manufactures and distributes cardiac stents, is eyeing a valuation of Rs 11,000-13,000 crore, they added.
According to the draft red herring prospectus (DRHP) filed on Thursday, Integris Medtech’s IPO comprises a fresh issue of equity worth Rs 925 crore and an offer for sale of 2.16 crore equity shares by promoters.
As part of the OFS, Evercure Holdings Pte Ltd, Gurmit Singh Chugh, and Punita Sharma will offload shares.
Proceeds of the fresh issue will primarily be used for payment of debt and general corporate purposes.
Backed by private equity player Everstone Capital, Integris Medtech may consider a pre-IPO placement for up to Rs 185 crore. If such placement is completed, the